Proteomics in Multiple Trauma to Identify Organ Failure
NCT ID: NCT02030327
Last Updated: 2022-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
85 participants
OBSERVATIONAL
2014-01-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Response After Muscle and Skeleton Trauma
NCT00710411
Quantification of Transition Metals
NCT02222779
Metabonomics Fingerprinting of Multiple Trauma
NCT01279239
Transcriptomic Profiling in Severely Injured Patients
NCT02508272
Inflammatory Cytokine Variations in Traumatic Injury Responses
NCT00593892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No trauma
n=5 patients
No interventions assigned to this group
trauma without organ dysfunction
n=40 patients
No interventions assigned to this group
trauma with organ dysfunction
n=40 patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* multiple trauma patients
* ISS \>16
Exclusion Criteria
* ISS \<16
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Köln
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jochen Hinkelbein
Priv.-Doz. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jochen Hinkelbein, MD
Role: PRINCIPAL_INVESTIGATOR
UK Köln
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.